Chimeric Protein–Protein Interface Inhibitors Allow Efficient Inhibition of Type III Secretion Machinery and Pseudomonas aeruginosa Virulence-Reference-Cited by-同舟云学术

Chimeric Protein–Protein Interface Inhibitors Allow Efficient Inhibition of Type III Secretion Machinery and Pseudomonas aeruginosa Virulence

Published:2019-09-17 Issue:11 Volume:5 Page:1843-1854
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Ngo Tuan-Dung¹^ORCID,Plé Sophie²¹,Thomas Aline²^ORCID,Barette Caroline³^ORCID,Fortuné Antoine²^ORCID,Bouzidi Younes²^ORCID,Fauvarque Marie-Odile³^ORCID,Pereira de Freitas Rossimiriam⁴^ORCID,Francisco Hilário Flaviane⁵,Attrée Ina¹^ORCID,Wong Yung-Sing²^ORCID,Faudry Eric¹^ORCID

Affiliation:

1. Univ. Grenoble Alpes, CEA, INSERM, CNRS, Bacterial Pathogenesis and Cellular Responses, UMR 1036/ERL 5261, 17 avenue des Martyrs, Grenoble 38054, France

2. Univ. Grenoble Alpes, CNRS, Département de Pharmacochimie Moléculaire, UMR 5063, ICMG FR 2607, 470 rue de la chimie, Grenoble 38000, France

3. Univ. Grenoble Alpes, CEA, Inserm, IRIG, BGE, Genetics & Chemogenomics, 17 avenue des Martyrs, Grenoble 38054, France

4. Universidade Federal de Minas Gerais, Departamento de Química, UFMG, Av Pres Antônio Carlos, 6627, Pampulha, Belo Horizonte, Minas Gerais 31270-901, Brazil

5. Universidade Federal de Ouro Preto, Departamento de Química, ICEB, Campus Universitário Morro do Cruzeiro, Ouro Preto, Minas Gerais 35400-000, Brazil

Funder

Agence Nationale de la Recherche

Association Vaincre la Mucoviscidose

Association Gregory Lemarchand

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.9b00154

Reference42 articles.

1. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis